A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
Clinical trial NCT05551741 · COMPLETED
Trial details
- NCT number
- NCT05551741
- Sponsor
- Immunobrain Checkpoint
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-02
- Primary completion
- 2025-12-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.